![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Huangshi Shixing Pharmaceutical Co., Ltd. Huangshi Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Azithromycin, Dihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-114 - Rev 00
This Chemical Type CEP, issued on July 31, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1649 associated with this CEP further emphasizes